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Background: Escherichia coli biofilm formation has mostly been assessed in specific
pathogenic E. coli groups. Here, we assessed the early biofilm formation (EBF), i.e.,
adhesion stage, using the BioFilm Ring Test R© on 394 E. coli clinical isolates (EC) [196
consecutively isolated (CEC) in 2016 and 198 ESBL-producing E. coli (ESBLEC) isolated
in 2015]. Then, biofilm-forming ability was contrasted with phylogroups, clonotypes
(fumC-fimH), and sequence types (STs), all being used to define clones, virulence factors
(VF), and FimB.
Result: According to both biofilm production levels at 2, 3, and 5 h, and EBF kinetics
over 5 h, CEC and ESBLEC isolates segregated into three EBF groups: strong (G1),
moderate (G2), and weak (G3) producers. At 2 h, strong producers were more frequent
among CEC (n = 28; 14.3%) than among ESBLEC (n = 8; 4%) (P = 0.0004). As CEC and
ESBLEC isolates showed similar individual EBF kinetics in each group, a comparison
of isolate features between each group was applied to gathered CEC and ESBLEC
isolates after 2 h of incubation, 2 h being the most representative time point of the
CEC and ESBLEC isolate segregation into the three groups. Phylogroup B2 displayed
by 51.3% of the 394 isolates was more frequent in G1 (77.8%) than in G3 (47.6%)
(P = 0.0006). The 394 isolates displayed 153 clones, of which 31 included at least
three isolates. B2-CH14-2-ST127, B2-CH40-22-ST131, B2-CH52-5/14-ST141, and
E-CH100-96-ST362 clones were associated with G1 (P < 0.03) and accounted for
41.7% of G1 isolates. B2-CH40-30-ST131 clone was associated with G3 (P < 0.0001)
and accounted for 25.5% of G3 isolates. VF mean was higher among G1 than among
G3 isolates (P < 0.001). FimB-P2 variant was associated with G1 (P = 0.0011)
and FimB-P1 variant was associated with G3 (P = 0.0023). Clone, some VF, and
FimB were associated with EBF, with clonal lineage being able to explain 72% of the
variability of EBF.
Conclusion: Among our 394 isolates, <10% are able to quickly and persistently
produce high biofilm levels over 5 h. These isolates belong to a few clones previously
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described in various studies as dominant gut colonizers in mammalians and birds
and comprised the B2-CH40-22-ST131 clone, i.e., the ancestor of the globally
disseminated B2-CH40-30-ST131 clone that is the dominant clone among the weak
biofilm producers.
Keywords: E. coli, early biofilm formation, phenotypes, virulence factors, clones, ST131, ST127, ST141
INTRODUCTION
Since the first definition of biofilms provided by Costerton et al.
(1978) 30 years ago, it is well established that the majority
of bacteria found in nature exists attached to surfaces within
the structured biofilm ecosystem (Costerton et al., 1978; Hall-
Stoodley et al., 2004). Bacterial biofilms are known for their
resistance to antibiotics, disinfectants, and components of the
innate and adaptative inflammatory defense system of the body
(Høiby et al., 2011). Accordingly, biofilm-growing bacteria cause
chronic infections, persisting inflammation, tissue damage, and
foreign body infections (Høiby et al., 2011). Thus, it was shown
that persistence of staphylococcal infections related to foreign
bodies is due to biofilm formation (Sabaté Brescó et al., 2017).
Likewise, chronic Pseudomonas aeruginosa lung infections in
cystic fibrosis patients are caused by biofilm-growing mucoid
isolates (Høiby et al., 2010).
Concerning Escherichia coli, which can exist as a harmless
commensal in the mammalian digestive tract and as a pathogen
causing significant morbidity and mortality worldwide, its
ability to form biofilm has been extensively studied from non-
pathogenic E. coli K12 strains (Beloin et al., 2008). With regard to
pathogenic E. coli, biofilm involvement in pathogenesis has been
well defined in diarrheagenic E. coli, notably enteroaggregative
E. coli (Sheikh et al., 2001; Sherlock et al., 2004; Schiebel et al.,
2017) and in adherent-invasive E. coli that have been implicated
in the origin and perpetuation of Crohn’s disease (Martinez-
Medina et al., 2009b). Production of biofilm by extraintestinal
pathogenic E. coli (ExPEC) was mostly assessed in uropathogenic
E. coli (Watts et al., 2010; Ponnusamy et al., 2012; Agarwal
et al., 2013; Tapiainen et al., 2014). All these studies highlighted
various biofilm formation phenotypes among uropathogenic
E. coli including isolates obtained from patients with an
indwelling catheter. Assessment of biofilm formation focusing on
the pandemic extended-spectrum β-lactamase (ESBL)-producing
and multidrug-resistant ST131 E. coli clone (Nicolas-Chanoine
et al., 2014) showed highly contrasting results: very low levels
(Novais et al., 2012) and moderate levels (Hussain et al., 2014)
of biofilm formation. Sarkar et al. (2016) studying ST131 isolates
expressing or non-expressing type 1 fimbriae showed that biofilm
growth depended on type 1 fimbriae expression and assay
conditions. We recently showed different phenotypes among
ST131 isolates according to their fimH allele encoding adhesins of
type 1 fimbriae, namely, significant higher levels of early biofilm
production by isolates of ST131 H22 subclone than those of
ST131 H30 subclone (Nicolas-Chanoine et al., 2017).
In the present study, we assessed biofilm formation in
394 clinical isolates obtained from different sources in two
geographically distant hospitals and during the same time
periods. We focused on the early biofilm formation (EBF), i.e.,
at adhesion stage, because this stage is the key stage in the
colonization process of abiotic and biotic surfaces, body biotic
surfaces being the epithelia of the various organs for the ExPEC
isolates and mucus layers in gut, i.e., the E. coli natural habitat,
for all E. coli populations (Ellermann and Sartot, 2018). For this,
we used the BioFilm Ring Test R©, a microbead immobilization
assay adapted from Chavant et al.’s (2007) method that was shown
to have a good concordance with the crystal violet method (Di
Domenico et al., 2016) and offers a reproducible and quantifiable
measure of the first step of biofilm formation. Expecting, as
previously described, different biofilm formation phenotypes
among our isolates, the main goal of this study was to molecularly
characterize the isolates that enabled us to show that some traits
are associated with the different phenotypes.
MATERIALS AND METHODS
Bacteria
Two collections of E. coli clinical isolates were studied. The first
collection consisted of 196 non-duplicate (one isolate per patient)
E. coli consecutively isolated (CEC) in 2016 from two hospitals
(Lugo hospital in Spain, n = 100, and Beaujon hospital in France,
n = 96). This collection that comprised 13 ESBL-producing
isolates came from different sources: 146 from urine, 22 from
blood, 5 from bile, 3 from ascitic fluid, 6 from abscesses, and
14 from various other sources. As ESBL production is currently
one of the most important worldwide threatening mechanisms of
antibiotic resistance in E. coli clinical isolates, we studied a second
collection consisting of 198 non-duplicate ESBL-producing E. coli
(ESBLEC) isolates obtained from the same two hospitals in 2015
(Lugo hospital, n = 99, and Beaujon hospital, n = 99). This
collection comprised 147 isolates from urine, 26 from blood,
7 from bile, 4 from ascitic fluid, 2 from abscesses, and 12
from various other sources. ESBL production detected by the
double disk synergy test (Jarlier et al., 1988) performed in the
two hospitals had been confirmed by specific ESBL PCR and
sequencing as previously described (Leflon-Guibout et al., 2008;
Mora et al., 2018).
Determination of Early Biofilm Formation
The kinetics of EBF was assessed using the BioFilm Ring
Test R© (BioFilm Control, Saint-Beauzire, France) according
to the manufacturer’s recommendations. Briefly, each isolate
was twice sub-cultured on brain heart infusion (BHI) agar
(Benton Dickinson, Le Pont-de-Claix, France) at 37◦C for 24 h.
Three colonies of the second subculture on BHI agar were
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suspended in BHI broth (Biofilm Control). Suspension was
standardized to an optical density at 600 nm of 1.00 ± 0.05
(Ultrospec10: Biochrom, Cambridge, United Kingdom) and then
diluted at 1:250 in BHI broth to obtain a final concentration
of approximately 106 UFC/ml. The bacterial suspension was
supplemented (1% vol/vol) with magnetic microbeads (TONER
4, Biofilm Control) and 200 µl of the mix was deposited in
two wells of three polystyrene 96-well microtiter plates that
were incubated for 2, 3, and 5 h, respectively. At the end
of each incubation time, 100 µl of liquid contrast solution
(LIC001, Biofilm Control) was added on the top of each
well and the microplate was put on a magnetic block for
1 min. After magnet contact, free beads were attracted toward
the center of each well, forming a brown spot, while beads
embedded in biofilms were blocked and remained undetectable.
Each microplate was scanned using a BioFilm Control plate
reader. The intensity of the spot was analyzed using the
BioFilm Ring Test R©-software version 3.0.3 and expressed as a
biofilm formation index (BFI) with values ranging from 20
(non-formation of biofilm) to 0 (high formation of biofilm)
that is inversely proportional to attached bacteria that block the
beads. BFI values ≤ 5 mean that the isolates are strong biofilm
producers; BFI values between 6 and 14, moderate producers;
BFI values between 15 and 19, weak producers; non-producers
display a BFI value of 20. Each isolate was tested in three
independent experiments and the average of the six measures
was used as the final BFI value. For each experiment, isolates
S250 and 39 previously described with the method carried
out in the present study as strong and negative producers of
biofilm, respectively, were used as controls (Nicolas-Chanoine
et al., 2017). We also included BHI broth without bacteria as
negative control.
Molecular Characterization of Isolates
As previously described, phylogroups (Clermont et al., 2013),
sequence types (STs) according to the MLST scheme of
Achtman1, fumC (C), and fimH (H) clonotypes (Weissman
et al., 2012), and virulence factors (VF) (Mora et al.,
2018) were determined in all 394 E. coli isolates. Clones
were characterized by using the association of phylogroup,
clonotype, and ST. Among the 394 isolates, 127 (approximately
one-third of the 394 isolates) were randomly selected by
using the RAND function (Microsoft Excel) system for
the fimB gene analysis. The fimB gene was amplified with
specific primers (FimB F: 5′-AGCATGGCGTTTGTATGG-
3′; FimB R: 5′-CCCTGGTATCTCAACTATCTCT-3′) and
sequenced as previously described (Nicolas-Chanoine et al.,
2017). When the fimB gene was disrupted, the detection
of the previously described IS3-like in H30 R isolates
(Totsika et al., 2011; Nicolas-Chanoine et al., 2017) was
performed by PCR using specific primers designed in this
study (FimBw F: 5′-AGCATGGCGTTTGTATGG-3′; IS
R: 5′-CTGAATGTGATGTGCCGATG-3′). Phylogenetic
tree of FimB variants was constructed by the UPGMA
method of MEGA 6.
1http://mlst.warwick.ac.uk/mlst/dbs/Ecoli
Statistical Analysis
Analysis of variance (ANOVA) test was performed to compare
the mean number of virulence genes and the association
of variables with biofilm formation phenotypes. Dichotomous
variables were described using enumeration and percentage, and
compared using two-tailed Fisher’s exact test. P-values < 0.05
were considered statistically significant. Correlation between
quantitative variables was assessed by Pearson correlation
coefficient, and the assessment of repeatability was via the Bland
and Altman (1986) statistical method. All analyses were carried
out by XLSTAT statistical software2.
Nucleotide Sequence Accession
Numbers
The 34 fimB gene sequences have been registered in
GenBank database under the following accession numbers:
MK301552 to MK301585.
RESULTS
Kinetics of Early Biofilm Formation
To assess the repeatability of the duplicate determination of
biofilm formation performed on each of the 394 isolates at
each time, we calculated Pearson’s correlation coefficient and
Bland and Altman (1986) analysis between the BFI obtained for
each determination. Pearson’s correlation coefficient was high
and constant over time: 0.96 at 2 h, 0.96 at 3 h, and 0.95 at
5 h (Supplementary Figure S1A), and the Bland and Altman
(1986) analysis showed that only 3.4% of values at 2 h, 5.5% at
3 h, and 6.8% at 5 h exceed the established standard deviation
(Supplementary Figure S1B).
Biofilm formation index values obtained at each time point
(2, 3, and 5 h) showed a distribution of both CEC and
ESBLEC isolates in the three levels of biofilm production (strong,
moderate, and weak production) defined according to the BFI
value ranges. After 2 h of incubation, strong producers (BFI: 0–5)
and moderate producers (BFI: 6–14) were more frequent among
CEC isolates than ESBLEC isolates (P = 0.004 and P = 0.0189,
respectively), whereas weak and non-producers (BFI: 15–20)
were more frequent among ESBLEC isolates than among CEC
isolates (P < 0.0001) (Table 1). After 3 h of incubation, such
significant differences were still observed between CEC and
ESBLEC isolates for the strong and weak producers but not for
the moderate producers. After 5 h of incubation, no significant
difference was observed between CEC and ESBLEC for the three
types of producers.
The study of individual BFI trajectories of the isolates of the
three 2-h groups over time showed that both CEC and ESBLEC
isolates displayed three distinct EBF kinetics. As indicated in
Figures 1A,A’, most of the 28 CEC (27 non-ESBL producers)
and the 8 ESBLEC strong biofilm producers at 2 h (average
BFI: 1 for the two collections) remained strong producers after
3 h (average BFI: 1 and 2, respectively) and 5 h (average
2https://www.xlstat.com
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TABLE 1 | Distribution of CEC and ESLEC isolates according to the biofilm index (BFI) values after 2, 3, and 5 h of incubation.
BFI range Number (%) of isolates P-valuea Number (%) of isolates P-valuea Number (%) of isolates P-valuea













0–5 28 (14.3) 8 (4.0) 0.0004 36 (18.4) 11 (5.6) < 0.0001 71 (36.2) 70 (35.4) 0.9164
6–14 20 (10.2) 8 (4.0) 0.0189 39 (19.9) 27 (13.6) 0.1064 41 (20.9) 45 (22.7) 0.7150
15–20 148 (75.5) 182 (91.9) < 0.0001 121 (61.7) 160 (80.8) < 0.0001 84 (42.9) 83 (41.9) 0.9188
aTwo-tailed P-values by Fisher’s exact test.
FIGURE 1 | Individual biofilm formation trajectories over time for the 394 isolates. Individual biofilm formation index (BFI) and average BFI values at each time point
(2, 3, and 5 h) are represented as blue lines and a red connected line, respectively, for CEC isolates (A–C) and as green lines and a red connected line, respectively,
for ESBLEC isolates (A’–C’). (A,A’) present the biofilm kinetics of the strong biofilm producers at 2 h (BFI≤5), (B,B’), the biofilm kinetics of the moderate producers at
2 h (BFI>5–≤14), and (C,C’), the biofilm kinetics of the weak (BFI>14 and <20) and the non-producers (BFI = 20) at 2 h.
BFI: 4 and 3, respectively) of incubation. Accordingly, these
isolates were classified into group 1 (G1) corresponding to
quickly and persistently strong biofilm producers. As indicated
in Figures 1B,B’, the 20 CEC and 8 ESBLEC moderate producers
at 2 h, with average BFI values of 11 and 13, respectively,
displayed a wider variability of BFI values at 3 and 5 h than
the strong producers. However, their average BFI at 3 h (7 and
11, respectively) and at 5 h (10 and 6, respectively) led us to
classify them as mostly moderate producers over the study period
[group 2 (G2)]. As indicated in Figures 1C,C’, the 148 CEC
and 182 ESBLEC weak producers at 2 h (average BFI: 18 for
CEC and ESBLEC) also displayed a wide variability of BFI values
at 3 and 5 h with a notable part of isolates becoming strong
producers at 5 h. However, the average BFI values were 17 for
CEC and 18 for ESBLSE isolates at 3 h, and 12 for CEC and
ESBLEC isolates at 5 h. Accordingly, we classified these isolates
into group G3 corresponding to weak biofilm producers. We
compared the individual BFI trajectories of all CEC isolates and
CEC isolates over time without the 13 ESBL-producing isolates
identified in this collection and found no significant difference
(data not shown).
Figure 1 shows that time point 2 h was the most representative
time point of the division of our E. coli population into three
groups. Accordingly, the comparisons between G1, G2, and G3
isolates will be made at time point 2 h in the rest of the study.
Furthermore, the similarity of the individual biofilm formation
kinetics of the CEC and ESBLEC isolates within each group led
us to characterize altogether the CEC and ESBLEC isolates of each
group in the rest of the study.
Characterization of Phylogroups,
Sequence Types, and Clones
Phylogroups
Most of the 394 isolates (51.3%) were assigned to phylogroup
B2. The remaining isolates were distributed into phylogroups A
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(15.0%), B1 (9.6%), C (9.6%), E (5.1%), F (5.1%), and D (4.3%).
Isolates belonging to phylogroup B2 were predominant among
G1, G2, and G3 isolates (Figure 2). The seven phylogroups (A,
B1, B2, C, D, E, and F) were detected among G3 isolates, four (A,
B1, B2, and D) among G2 isolates, and four (B1, B2, E, and F)
among G1 isolates (Figure 2). Isolates belonging to phylogroup
B2 were more frequent among G1 isolates (77.8%) than among
G3 isolates (47.6%) (P = 0.0006) (Supplementary Table S1).
By contrast, isolates belonging to phylogroups A and C were
significantly more frequent among G3 isolates than among G1
isolates (A: 16.1% vs. 0%, P = 0.0098; C: 11.5% vs. 0%, P = 0.0419)
(Supplementary Table S1).
Sequence Types
The 394 E. coli isolates displayed 99 STs. The most frequent
STs accounting for more than half (52.0%) of the isolates were
ST131 (26.4%), ST73 (5.6%), ST10 (4.3%), ST88 (4.3%), ST141
(4.1%), ST69 (3.8%), and ST95 (3.6%). The distribution of the
seven most frequent STs among G1, G2, and G3 isolates is
presented in Figure 3. These seven STs were displayed by G3
isolates whereas five were displayed by G2 isolates (absence
of ST88 and ST95) and only three (ST131, ST141, and ST73)
were displayed by G1 isolates. Among the three STs shared
by the three groups, ST131 was significantly more frequent
among G3 isolates than among G1 isolates (29.4% vs. 11.1%,
P = 0.0289). By contrast, ST141 was more frequent among
G1 isolates than among G3 (25.0% vs. 1.5%, P < 0.0001)
(Supplementary Table S2).
Clones
A total of 153 clones were identified among the 394 isolates,
with 31 of them including at least 3 isolates (Figure 4
and Supplementary Table S3) and 6 including at least 10
isolates: B2-CH40-30-ST131 (87 isolates), D-CH35-27-ST69
(14 isolates), B2-CH52-5-ST141 (13 isolates), C-CH4-39-ST88
(11 isolates), A-CH11-54-ST10 (10 isolates), and B2-CH40-41
ST131 (10 isolates). The 36 G1 isolates belonged to 26 clones
(Supplementary Table S4). These 26 clones were also found in
25% of the G2 isolates (P < 0.0001) and in only 5.2% of the G3
isolates (P < 0.0001) (Supplementary Table S4).
Five clones (B2-CH14-2-ST127, B2-CH40-22-ST131,
B2-CH52-5-ST14, B2-CH52-14-ST141, and E-CH100-96-ST362)
were associated with G1 and accounted for 41.7% of G1
isolates, 10.7% of G2 isolates (P = 0.0105), and 2.4% of G3
isolates (P < 0.0001) (Supplementary Table S3). Only the
B2-CH40-30-ST131 clone was associated with G3, accounting
for 25.5% of G3 isolates, 10.7% of G2 isolates (P = 0.1068), and
0% of G1 isolates (P < 0.0001) (Supplementary Table S3).
FIGURE 2 | Distribution of phylogroups A, B1, B2, C, D, E, and F among G1, G2, and G3 isolates. G1: strong producers, G2: moderate producers, and G3: weak
producers. Isolates belonging to phylogroup B2 were more frequent among G1 isolates (77.8%) than among G3 isolates (47.6%) (P = 0.0006). By contrast, isolates
belonging to phylogroups A and C were significantly more frequent among G3 isolates than among G1 isolates (A: 16.1 vs. 0%, P = 0.0098; C: 11.5 vs. 0%,
P = 0.0419).
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FIGURE 3 | Distribution of the most frequent sequence types (STs) among G1, G2, and G3 isolates. G1: strong producers, G2: moderate producers, and G3: weak
producers. ST141 was more frequent among G1 isolates than among G3 (25.0 vs. 1.5%, P < 0.0001). By contrast, ST131 was significantly more frequent among
G3 isolates than among G1 isolates (29.4 vs. 11.1%, P = 0.0289).
Comparison of the Virulence Factor
(VF)-Encoding Genes Among G1, G2, and
G3 Isolates
As indicated in Table 2, some VF-encoding genes were mostly
observed among G1. These genes consisted of genes encoding
adhesins (papAH, papC, papEF, sfa/focDE, and yfcV), genes
encoding toxins (cnf1, hlyA, and vat), genes encoding two
variants of group II capsule (kpsM II-K5 and neuC-K1), and
miscellaneous genes (ibeA, malX, and ups). Inversely, the sat
and traT genes were mostly observed among G3 isolates.
Concerning the genes encoding proteins involved in iron uptake,
those encoding ferric aerobactin receptors (iucD and iutA) were
significantly more frequent among G3 isolates than among G1
isolates, whereas it was the contrary for the iroN and chuA genes.
Mean of VF-encoding genes was significantly higher among G1
isolates than among G3 isolates (13.8 vs. 10.4, P < 0.001).
fimB Alleles
Given that the ST131 clone with a fimH30 allele was the
dominant clone among our E. coli population and that
previous results had shown (i) an IS3-like-linked defective
fimB gene encoding a co-factor of the regulation of the type 1
fimbriae synthesis in this clone (Totsika et al., 2011) and (ii)
the key role played by type 1 fimbriae in promoting biofilm
formation in this clone (Sarkar et al., 2016), we analyzed the
fimB gene in 127 isolates randomly selected among the 394
isolates. PCR experiments showed no fimB amplicon in 10
(7.9%) isolates (Supplementary Table S5) belonging to the
following clones: A-CH11-0-ST93 (n = 2), A-CH11-0-ST167
(n = 1), A-CH99-54-ST361 (n = 1), A-CH7-53-ST540
(n = 1), A-CH7-54-ST540 (n = 1), A-CH4-0-ST1284 (n = 1),
B1-CH4-0-ST155 (n = 1), B2-CH38-92-ST421 (n = 1), and
E-CH26-0-ST38 (n = 1). An expected amplicon was detected
in 89 (70.1%) isolates and an amplicon with a higher size was
detected in 28 (22.0%) isolates (Supplementary Table S5).
Sequencing experiments showed the insertion of IS3-like in the
fimB gene in these 28 (22%) isolates comprising 25 of the 26
selected CH40-30 ST131 isolates and the three selected CH24-30
ST73 isolates. Overall, an intact fimB gene was significantly more
frequent among G1 isolates than among G3 isolates (P = 0.03)
(Supplementary Table S5).
Through fimB gene sequencing of the 89 isolates with
an expected fimB amplicon, 34 fimB alleles were detected
(Supplementary Table S6), of which 11 new variants compared
with those currently registered in the GenBank database. These
34 alleles encoded 10 FimB proteins (P1 to P10) (Supplementary
Table S6). Phylogenetic tree built with these 10 proteins
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FIGURE 4 | Distribution of the 31 clones including at least three isolates among G1, G2, and G3. G1: strong producers, G2: moderate producers, and G3: weak
producers. Five clones (B2-CH14-2-ST127, B2-CH40-22-ST131, B2-CH52-5-ST14, B2-CH52-14-ST141, and E-CH100-96-ST362) were associated with G1 and
accounted for 41.7% of G1 isolates, 10.7% of G2 isolates (P = 0.0105), and 2.4% of G3 isolates (P < 0.0001). Only the B2-CH40-30-ST131 clone was associated
with G3, accounting for 25.5% of G3 isolates, 10.7% of G2 isolates (P = 0.1068), and 0% of G1 isolates (P < 0.0001).
(Supplementary Figure S2) revealed two large clusters. One
of these clusters included the 14 alleles encoding FimB P1
and the other one included the eight alleles encoding FimB
P2. FimB P2 and the closely related FimB P3 (Supplementary
Figure S2) were associated with G1 and accounted for 69.2%
of G1 isolates vs. 10.6% of G3 isolates (P < 0.0001). Inversely,
FimB P1 was associated with G3, accounting for 69.7% of G3
isolates vs. 23.1% of G1 isolates (P = 0.0023) (Figure 5 and
Supplementary Table S7).
Correlation Between Biofilm Production
and Bacterial Characteristics
The one-way ANOVA test using the individual BFI of 394 isolates
showed that clonal lineage explained 72% of the EBF variability
and FimB, 28%. Among the VF-encoding genes significantly
associated with biofilm production, the sfa/focDE, cnf1, hlyA,
vat, and iroN genes were those explaining from 8 to 16% of the
variability of early biofilm production. Isolate source was not
associated with the EBF.
DISCUSSION
Our study that assessed the early biofilm production, i.e.,
adhesion stage of 394 E. coli clinical isolates obtained from
different sources, at the same time periods, in two distant
hospitals (Spanish and French hospitals), is in accordance
with previous studies with regard to the wide spectrum of
biofilm formation within ExPEC (Ponnusamy et al., 2012;
Agarwal et al., 2013; Mostafavi et al., 2018). Using the BioFilm
Ring Test R© like us, Olivares et al. (2016) found that P. aeruginosa
causing infection in cystic fibrosis patients segregated into three
groups (strong, moderate, and weak producers) at the early stage
of biofilm formation. Accordingly, difference in ability to quickly
adhere seems to exist within isolates of different bacterial species.
The biofilm production displayed by our ESBLEC collection is
also in accordance with that displayed by the ESBLEC collection
recently published by Surgers et al. (2018), i.e., predominance of
weak biofilm producers among ESBLEC.
The novelty provided by our study consisted of the molecular
characterization of the 394 isolates with regard to phylogroups,
clonal lineages, VF-encoding genes, and FimB, a co-factor of the
regulation of the synthesis of type 1 fimbriae that are critical
adhesins for E. coli biofilm formation (Beloin et al., 2008). Thus,
we showed that among the characteristics significantly associated
with EBF, clonal lineage was the most suitable characteristics to
explain the variability of EBF. Association between clonal lineage
and EBF phenotype has recently been shown among bone and
joint infection Staphylococcus aureus isolates analyzed by using
the BioFilm Ring Test R© (Tasse et al., 2018).
Among the limited number (<10%) of our E. coli that
quickly and persistently produced early biofilm at high levels
(G1 isolates), five clones (B2-CH14-2-ST127, CH52-5, and
CH52-14 sub-lineages of B2-ST141, B2-CH40-22-ST131, and
E-CH100-96-ST362) accounted for 41.7% of the 36 G1 isolates.
Notable features have previously been provided by different
studies for these clones. The B2-ST127 clone, which is
one of the dominant clones among uropathogenic isolates
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TABLE 2 | Virulence factor-encoding genes displayed by G1, G2, and G3 isolates.









G1 vs. G2 G1 vs. G3
Adhesin
fimH 383 (97.2) 36 (100) 27 (96.4) 320 (97)
fimAVMT78 56 (14.2) 4 (11.1) 4 (14.3) 48 (14.5)
papAH 135 (34.3) 19 (52.8) 12 (42.9) 104 (31.5) 0.0149b
papC 140 (35.5) 20 (55.6) 12 (42.9) 108 (32.7) 0.0093b
papEF 146 (37.1) 20 (55.6) 13 (46.4) 113 (34.2) 0.0168b
sfa/focDE 69 (17.5) 22 (61.1) 9 (32.1) 38 (11.5) 0.0259a <0.0001b
afa/dra BC 31 (7.9) 0 (0.0) 1 (3.6) 30 (9.1)
yfcV 213 (54.1) 31 (86.1) 17 (60.7) 165 (50) 0.0396a <0.0001b
Toxin
sat 130 (33) 3 (8.3) 7 (25) 120 (36.4) 0.0006b
cnf1 74 (18.8) 17 (47.2) 12 (42.9) 45 (13.6) <0.0001b
hlyA 80 (20.3) 17 (47.2) 13 (46.4) 50 (15.2) <0.0001b
hlyF 77 (19.5) 6 (16.7) 4 (14.3) 67 (20.3)
cdtB 17 (4.3) 4 (11.1) 0 (0.0) 13 (3.9)
tsh 21 (5.3) 2 (5.6) 2 (7.1) 17 (5.2)
vat 99 (25.1) 23 (63.9) 15 (53.6) 61 (18.5) <0.0001b
Iron uptake
iucD 237 (60.2) 8 (22.2) 13 (46.4) 216 (65.5) <0.0001b
IutA 239 (60.7) 8 (22.2) 13 (46.4) 218 (66.1) <0.0001b
iroN 129 (32.7) 25 (69.4) 14 (50) 90 (27.3) <0.0001b
fyuA 295 (74.9) 29 (80.6) 21 (75) 245 (74.2)
chuA 260 (66) 33 (91.7) 21 (75) 206 (62.4) 0.0008b
Capsule
KpsM II 229 (58.1) 30 (83.3) 18 (64.3) 181 (54.8) 0.0011b
KpsM II-K2 31 (7.9) 0 (0.0) 1 (3.6) 30 (9.1)
KpsM II-K5 151 (38.3) 21 (58.3) 13 (46.4) 117 (35.5) 0.0105b
neuC-K1 47 (11.9) 9 (25) 4 (14.3) 34 (10.3) 0.0153b
KpsM III 8 (2.0) 0 (0.0) 1 (3.6) 7 (2.1)
Miscellaneous
cvaC 58 (14.7) 6 (16.7) 3 (10.7) 49 (14.8)
iss 72 (18.3) 8 (22.2) 3 (10.7) 61 (18.5)
traT 256 (65) 15 (41.7) 13 (46.4) 228 (69.1) 0.0014b
ibeA 36 (9.1) 12 (33.3) 1 (3.6) 23 (7.0) 0.004b <0.0001b
malX 226 (57.4) 31 (86.1) 17 (60.7) 178 (53.9) 0.0396a 0.0003b
usp 211 (53.6) 28 (77.8) 17 (60.7) 166 (50.3) 0.0024b
ompT 282 (71.6) 30 (83.3) 22 (78.6) 230 (69.7)
Range 1–23 1–23 1–20 1–22
Mean 10.8 13.8 11.8 10.4 0.001c 0.001c
aTwo-tailed P-values by Fisher’s exact test are shown where P < 0.05. bSignificant differences after applying the Bonferroni correction because of P < 0.025. cAnalysis
of variance (ANOVA test) was performed to compare the mean of virulence genes between the three groups.
(Yamaji et al., 2018), was shown to be shared by humans, dogs,
and cats (Johnson et al., 2008) and to be a dominant gut colonizer
of humans (Ulleryd et al., 2015) and fruit bats (Nowak et al.,
2017). The B2-ST141 clone was characterized by Clermont et al.
(2017) as a commensal clone, i.e., digestive tract resident with
low level of human invasiveness, through a study assessing the
pathogenesis of bacteriaemic E. coli by matching large collections
of bacteriaemic (Lefort et al., 2011) and commensal isolates
(Massot et al., 2016). Other studies showed that this clone
accounted for the gut dominant E. coli population of some
healthy subjects (Leflon-Guibout et al., 2008; Nicolas-Chanoine
et al., 2013) and was one of the dominant clones in the digestive
tract of Antarctic pinnipeds (Mora et al., 2018). The B2-CH40-22
ST131 clone was shown to have similar features to the B2-CH52-5
ST141 clone with regard to healthy subjects (Nicolas-Chanoine
et al., 2017) and Antarctic pinnipeds (Mora et al., 2018). It was
also found in poultry digestive tract and retail chicken meat and
was shown to be a foodborne uropathogen (Liu et al., 2018).
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FIGURE 5 | Distribution of the FimB protein (P) variants among G1, G2, and
G3 isolates. G1: strong producers, G2: moderate producers, and G3: weak
producers. FimB P2 and the closely related FimB P3 were associated with G1
and accounted for 69.2% of G1 isolates vs. 10.6% of G3 isolates
(P < 0.0001). Inversely, FimB P1 was associated with G3 accounting for
69.7% of G3 isolates vs. 23.1% of G1 isolates (P = 0.0023).
Concerning the E-CH100-96 ST362 clone, our study is, to our
knowledge, the first one reporting the presence of this clone in
humans. Indeed, it was identified so far in chicken (Cortes et al.,
2010) and as an agent causing bovine mastitis (Freitag et al.,
2017). Accordingly, most of these clones appear to be both ExPEC
and intestinal dominant colonizers in some mammals and birds.
We found that some VF genes, including papC, sfa/focDE,
cnf1, hlyA, and ibeA, were mostly identified in G1 isolates,
i.e., strong biofilm producers. All these VFs had already been
shown to be associated with E. coli strong biofilm producers
(Naves et al., 2008), and two of them, sfa/focDE and ibeA,
had been shown to be characteristic traits of adherent/invasive
E. coli (AIEC) that are strong biofilm producers (Martinez-
Medina et al., 2009b). The implication of AIEC in Crohn’s
disease (Darfeuille-Michaud et al., 2004) was notably based
on their high biofilm production. Indeed, in an inflamed
intestinal environment, their biofilm-related mucosal attachment
could allow them to penetrate the inner mucus layer and
adhere to the epithelial surface, thus enabling more direct
stimulation of epithelial and immune cells (Glasser et al.,
2001; Ellermann and Sartot, 2018). It is interesting to note
here that Martinez-Medina et al. (2009a) found two ST131
isolates carrying the ibeA gene in the AIEC collection that
they compared with ExPEC isolates. This finding suggests
that it would be of interest to investigate all the AIEC
phenotypic and genotypic features in our strong biofilm
producers (Camprubí-Font et al., 2019).
The present study in which a wide collection of E. coli
isolates was analyzed confirms the results that we previously
obtained with few isolates about the difference in early
biofilm production between B2-CH40-22 ST131 and
B2-CH40-30-ST131 clones, i.e., strong and weak production,
respectively (Nicolas-Chanoine et al., 2017). Knowing that
the B2-CH40-22 ST131 clone is the ancestor of the globally
disseminated B2-CH40-30-ST131 clone (Ben Zakour et al.,
2016), the loss of the ability to strongly produce biofilm at the
early step of biofilm formation by the B2-CH40-30-ST131
clone could appear as an evolutionary adaptative trait
in ST131 lineage.
In conclusion, this study highlights that the ability to quickly
and persistently produce biofilm at high levels is a property
displayed by a limited number of clones, some of which have
been found in previous studies as dominant colonizers in some
mammals and birds.
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